A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
Clinical trial NCT05153434 · COMPLETED
Trial details
- NCT number
- NCT05153434
- Sponsor
- Aardvark Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2024-09-24
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.